» Articles » PMID: 39897057

Machine Learning Methods for Histopathological Image Analysis: Updates in 2024

Overview
Date 2025 Feb 3
PMID 39897057
Authors
Affiliations
Soon will be listed here.
Abstract

The combination of artificial intelligence and digital pathology has emerged as a transformative force in healthcare and biomedical research. As an update to our 2018 review, this review presents comprehensive analysis of machine learning applications in histopathological image analysis, with focus on the developments since 2018. We highlight significant advances that have expanded the technical capabilities and practical applications of computational pathology. The review examines progress in addressing key challenges in the field as follows: processing of gigapixel whole slide images, insufficient labeled data, multidimensional analysis, domain shifts across institutions, and interpretability of machine learning models. We evaluate emerging trends, such as foundation models and multimodal integration, that are reshaping the field. Overall, our review highlights the potential of machine learning in enhancing both routine pathological analysis and scientific discovery in pathology. By providing this comprehensive overview, this review aims to guide researchers and clinicians in understanding the current state of the pathology image analysis field and its future trajectory.

References
1.
Echle A, Rindtorff N, Brinker T, Luedde T, Pearson A, Kather J . Deep learning in cancer pathology: a new generation of clinical biomarkers. Br J Cancer. 2020; 124(4):686-696. PMC: 7884739. DOI: 10.1038/s41416-020-01122-x. View

2.
Zhang X, Wang S, Rudzinski E, Agarwal S, Rong R, Barkauskas D . Deep Learning of Rhabdomyosarcoma Pathology Images for Classification and Survival Outcome Prediction. Am J Pathol. 2022; 192(6):917-925. PMC: 9194647. DOI: 10.1016/j.ajpath.2022.03.011. View

3.
Yamashita R, Long J, Longacre T, Peng L, Berry G, Martin B . Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study. Lancet Oncol. 2021; 22(1):132-141. DOI: 10.1016/S1470-2045(20)30535-0. View

4.
Cho U, Im S, Park H . Exploring histological predictive biomarkers for immune checkpoint inhibitor therapy response in non-small cell lung cancer. J Pathol Transl Med. 2024; 58(2):49-58. PMC: 10948248. DOI: 10.4132/jptm.2024.01.31. View

5.
Coudray N, Ocampo P, Sakellaropoulos T, Narula N, Snuderl M, Fenyo D . Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat Med. 2018; 24(10):1559-1567. PMC: 9847512. DOI: 10.1038/s41591-018-0177-5. View